Abbott GmbH & Co. KG
Industry / private company
Location:
Wiesbaden,
Germany (DE)
ISNI: 0000000405356583
ROR: https://ror.org/02x2gk324
Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study. (2021)
Geller JC, Woehrle A, Busch M, Elsaesser A, Kleemann T, Birkenhauer F, Bramlage P, Veltmann C
Journal article
Results of Multicenter Evaluation of Plug Use for LVAD Explantation (2021)
Potapov E, Politis N, Rieger S, Karck M, Weyand M, Walther T, Emrich F, et al.
Conference contribution
Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry (2019)
Huseynov A, Baumann S, Nef H, Riemer T, Schneider S, Pfannenbecker T, Achenbach S, et al.
Journal article
Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy (2018)
Woehrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Muenzel T, et al.
Journal article
Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R) (2016)
Nef H, Wiebe J, Achenbach S, Muenzel T, Naber C, Richardt G, Mehilli J, et al.
Journal article